Angioedema Secondary to Angiotensin Converting Enzyme Inhibitors

Authors

  • T Thiruventhiran
  • Ho Bee Kiau

Abstract

Angioedema due to whatever cause is potentially life threatening, especially if it involves the head and neck region. Patients at risk need to be identified and precautionary measures are necessary. The use of Angiotensin Converting Enzyme Inhibitors (ACEIS) has been associated with angioedema of the face and tongue. Its widespread use has resulted in an increased awareness of this rare but important complication. We report here a case of angioedema secondary to ACEIS developing a few months after initiation of therapy and discuss its clinical importance.

Downloads

Download data is not yet available.

Downloads

Published

1999-12-27

Issue

Vol. 4 No. 2 (1999)

Section

Research article

License

All authors agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0 to allow others to freely access, copy and use research provided the author is correctly attributed, unless otherwise stated. All articles are available online without charge or other barriers to access. However, anyone wishing to reproduce large quantities of an article (250+) should inform the publisher. Any opinion expressed in the articles are those of the authors and do not reflect that of the University of Malaya, 50603 Kuala Lumpur, Malaysia.